Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6037346A · kind A · utility
130Cited by
12References
94Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 1998 |
| Grant date | Mar 14, 2000 |
| Priority date | — |
| Expiry date | Oct 27, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for treating erectile dysfunction in a mammalian male individual. The method involves the local administration of a phosphodiesterase inhibitor or a pharmaceutically acceptable salt, ester, amide or derivative thereof within the context of an effective dosing regimen. A preferred mode of administration is transurethral. Pharmaceutical formulations and kits are provided as well.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.